Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus

NCT00379145 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

NETWORK

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: trabectedin

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]